Article Information
- Received January 21, 2013
- Revision received August 12, 2013
- Accepted August 12, 2013
- First published September 18, 2013.
- Version of record published September 18, 2013.
Author Information
- Min Jung Kwon1,3,
- Jinha Kim1,3,
- Haeyoung Shin1,3,
- Soo Ryeong Jeong1,
- Young Mi Kang1,
- Jun Young Choi1,2,3,
- Dong Hoon Hwang1,3, and
- Byung Gon Kim1,2,3
- 1Brain Disease Research Center, Institute for Medical Sciences and
- 2Department of Neurology, Ajou University School of Medicine, Suwon, 443-721, Republic of Korea and
- 3Neuroscience Graduate Program, Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, 443-721, Republic of Korea
Author contributions
Author contributions: M.J.K. and B.G.K. designed research; M.J.K., J.K., H.S., S.R.J., Y.M.K., J.Y.C., and D.H.H. performed research; M.J.K. and B.G.K. analyzed data; M.J.K. and B.G.K. wrote the paper.
Disclosures
- Received January 21, 2013.
- Revision received August 12, 2013.
- Accepted August 12, 2013.
This work was supported by National Research Foundation of Korea Grants 2012R1A2A2A01013143 and 2012R1A5A2051429 (MRC) and 2009-0081467 funded by the Korean government (Ministry of Science, ICT, and Future Planning) and Korean Health Technology R & D Project, Ministry for Health, Welfare, and Family Affairs Grants A101663 (D.H.H.) and A101565 (J.Y.C.). We thank Drs. Benowitz and Yin at Harvard Medical School (Boston, MA) for providing neutralizing antibody against oncomodulin and relevant discussions. We also thank to Dr. Henzl at University of Missouri (Columbia, MO) for the permission to use a precious reagent developed from his laboratory.
The authors declare no competing financial interests.
- Correspondence should be addressed to Dr. Byung G. Kim, Brain Disease Research Center, Institute for Medical Sciences, and Department of Neurology, Ajou University School of Medicine, Suwon 443-721, Korea. kimbg{at}ajou.ac.kr
Online Impact